Posted: 20 Jun 2014 10:08 AM PDT
Cancers driven by – and dependent on – the potent mutated cancer gene KRAS have an especially poor prognosis, and three decades of scientific attempts have failed to produce drugs that can attack KRAS and halt the tumors’ runaway growth.
|You are subscribed to email updates from Science News from SciGuru.com |
To stop receiving these emails, you may unsubscribe now.
|Email delivery powered by Google|
|Google Inc., 20 West Kinzie, Chicago IL USA 60610|